{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:33:47Z","timestamp":1791351227603,"version":"4.3.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92242-y","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:07:23Z","timestamp":1744049243000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Antiviral effect of Bromelain combined with acetylcysteine against SARS-CoV-2 Omicron variant"],"prefix":"10.1038","volume":"15","author":[{"given":"Erik Vinicius de Sousa","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linziane Lopes","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Alves","family":"Clarindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovane","family":"Marques-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Camilo","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds de F\u00e1tima Silva","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Debortoli","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Guimar\u00e3es","family":"da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano de Paula","family":"Sabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew Suji","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Grazziela Alves","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"92242_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.5642","volume":"254","author":"LE van Eijk","year":"2021","unstructured":"van Eijk, L. E. et al. COVID-19: Immunopathology, pathophysiological mechanisms, and treatment options. J. Pathol. 254, 307\u2013331 (2021).","journal-title":"J. Pathol."},{"key":"92242_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-34186-9","volume":"13","author":"J Douglas","year":"2022","unstructured":"Douglas, J. et al. Tracing the international arrivals of SARS-CoV-2 Omicron variants after aotearoa new Zealand reopened its border. Nat. Commun. 13, 1\u201310 (2022).","journal-title":"Nat. Commun."},{"key":"92242_CR3","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abd4251","volume":"369","author":"Y Cai","year":"2020","unstructured":"Cai, Y. et al. Distinct conformational states of SARS-CoV-2 spike protein. Science 369, 1586\u20131592 (2020).","journal-title":"Science"},{"key":"92242_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/v13030425","volume":"13","author":"J Akhter","year":"2021","unstructured":"Akhter, J. et al. The combination of bromelain and acetylcysteine (Bromac) synergistically inactivates SARS-CoV-2. Viruses 13, 425 (2021).","journal-title":"Viruses"},{"key":"92242_CR5","doi-asserted-by":"publisher","first-page":"112753","DOI":"10.1016\/j.biopha.2022.112753","volume":"148","author":"JGA Coelho-dos-Reis","year":"2022","unstructured":"Coelho-dos-Reis, J. G. A. et al. Ex-vivo mucolytic and anti-inflammatory activity of bromac in tracheal aspirates from COVID-19. Biomed. Pharmacother. 148, 112753 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"92242_CR6","doi-asserted-by":"crossref","unstructured":"Pillai, K., Ehteda, A., Akhter, J., Chua, T. C. & Morris, D. L. Anticancer effect of bromelain with and without cisplatin or 5-FU on malignant peritoneal mesothelioma cells. Anticancer Drugs 2,150 \u2013 60  (2014).","DOI":"10.1097\/CAD.0000000000000039"},{"key":"92242_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-32547-y","volume":"13","author":"JT Castro","year":"2022","unstructured":"Castro, J. T. et al. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein. Nat. Commun. 13, 1\u201316 (2022).","journal-title":"Nat. Commun."},{"key":"92242_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance 25, 1 (2020).","journal-title":"Eurosurveillance"},{"key":"92242_CR9","unstructured":"Therapeutic Goods Association. Australian product information-lagevrio\u00ae (molnupiravir) Capsules 1 NAME OF THE MEDICINE (2023)."},{"key":"92242_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1073\/pnas.2022586118","volume":"118","author":"DJ Benton","year":"2021","unstructured":"Benton, D. J. et al. The effect of the D614G substitution on the structure of the Spike glycoprotein of SARS-CoV-2. Proc. Natl. Acad. Sci. 118, 9 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"92242_CR11","unstructured":"World Health Organization (WHO). https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants (2024)."},{"key":"92242_CR12","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3904\/kjim.2019.105","volume":"35","author":"PH Lee","year":"2020","unstructured":"Lee, P. H., Hong, J. & Jang, A. S. N-acetylcysteine decreases airway inflammation and responsiveness in asthma by modulating Claudin 18 expression. Korean J. Intern. Med. 35, 1229\u20131237 (2020).","journal-title":"Korean J. Intern. Med."},{"key":"92242_CR13","doi-asserted-by":"crossref","unstructured":"Poppe, M. et al. The NF-\u03baB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells. PLoS Pathog. 13 (2017).","DOI":"10.1371\/journal.ppat.1006286"},{"key":"92242_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.15407\/ubj93.05.043","volume":"93","author":"AH Shntaif","year":"2021","unstructured":"Shntaif, A. H., Alrazzak, N. A., Bader, A. & Almarzoqi, A. M. Determination the binding ability of n-acetyl cysteine and its derivatives with sars-cov-2 main protease using molecular docking and molecular dynamics studies. Ukr. Biochem. J. 93, 43\u201351 (2021).","journal-title":"Ukr. Biochem. J."},{"key":"92242_CR15","doi-asserted-by":"publisher","first-page":"717757","DOI":"10.3389\/fphar.2021.717757","volume":"12","author":"TE Tallei","year":"2021","unstructured":"Tallei, T. E. et al. An analysis based on molecular docking and molecular dynamics simulation study of bromelain as anti-SARS-CoV-2 variants. Front. Pharmacol. 12, 717757 (2021).","journal-title":"Front. Pharmacol."},{"key":"92242_CR16","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3390\/nu14153045","volume":"14","author":"MF Abuzinadah","year":"2022","unstructured":"Abuzinadah, M. F., Ahmad, V., Al-Thawdi, S., Zakai, S. A. & Jamal, Q. M. Exploring the binding interaction of active compound of pineapple against foodborne bacteria and novel coronavirus (SARS-CoV-2) based on molecular docking and simulation studies. Nutrients 14, 3045 (2022).","journal-title":"Nutrients"},{"key":"92242_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2020","unstructured":"V\u2019kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: Implications for SARS-CoV-2. Nat. Rev. Microbiol. 19, 155\u2013170 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"92242_CR18","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.3390\/nu13124313","volume":"13","author":"P Hikisz","year":"2021","unstructured":"Hikisz, P. & Bernasinska-Slomczewska, J. Beneficial properties of bromelain. Nutrients 13, 4313 (2021).","journal-title":"Nutrients"},{"key":"92242_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/ctm2.281","volume":"11","author":"S Sagar","year":"2021","unstructured":"Sagar, S. et al. Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and Spike protein. Clin. Transl. Med. 11, 281 (2021).","journal-title":"Clin. Transl. Med."},{"key":"92242_CR20","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.3389\/fmicb.2020.01796","volume":"11","author":"R Alexpandi","year":"2020","unstructured":"Alexpandi, R., de Mesquita, J. F., Pandian, S. K. & Ravi, A. V. Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: An in Silico analysis. Front. Microbiol. 11, 1796 (2020).","journal-title":"Front. Microbiol."},{"key":"92242_CR21","doi-asserted-by":"publisher","first-page":"866474","DOI":"10.3389\/fgene.2022.866474","volume":"13","author":"S Ahamad","year":"2022","unstructured":"Ahamad, S., Ali, H., Secco, I., Giacca, M. & Gupta, D. Anti-fungal drug Anidulafungin inhibits SARS-CoV-2 spike-induced syncytia formation by targeting ACE2-spike protein interaction. Front. Genet. 13, 866474 (2022).","journal-title":"Front. Genet."},{"key":"92242_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-021-00249-2","volume":"7","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. SARS-CoV-2 cell tropism and multiorgan infection. Cell. Discov. 7, 1\u20134 (2021).","journal-title":"Cell. Discov."},{"key":"92242_CR23","doi-asserted-by":"crossref","unstructured":"Chen, H. et al. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. eBioMedicine 70, 103500 (2021).","DOI":"10.1016\/j.ebiom.2021.103500"},{"key":"92242_CR24","first-page":"13","volume":"3","author":"JJ Gon\u00e7alves","year":"2022","unstructured":"Gon\u00e7alves, J. J. Timeline kinetics of systemic and airway immune mediator storm for comprehensive analysis of disease outcome in critically ill covid-19 patients. Front. Immunol. 3, 13 (2022).","journal-title":"Front. Immunol."},{"key":"92242_CR25","first-page":"14","volume":"13","author":"GM Ferreira","year":"2023","unstructured":"Ferreira, G. M. et al. Taming the SARS-CoV-2-mediated proinflammatory response with BromAc\u00ae. Front. Immunol. 13, 14 (2023).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92242-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T18:07:40Z","timestamp":1744049260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92242-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. DLM, SJV and MSE are employed by MucPharm. All the remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Research was approved by Institutional Research Board Committee. This research had approval from the Brazilian Institutional Ethics Committee (Approval number: 45919121.6.0000.5526). There was written consent from the next of kin on behalf of the patients for participation in the research. This study followed the principles of the Helsinki Declaration and resolution #466\/2012 of the Brazilian Ministry of Health for research involving human subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained by next of kin of all participants enrolled in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"11882"}}